Cooley is advising Brightree on its $800 million sale to ResMed, a tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care. Subject to customary closing conditions, the transaction is anticipated to close by the end of June.
"ResMed Pays $800M for Health Care Software Co. Brightree," Law360
"ResMed Buys Health IT Firm Brightree," The Deal
"Medical-Device Maker ResMed Buys Software Developer Brightree," Mergers & Acquisitions